Health knowledge made personal
› Share page:

Posts

Sort by: Most recent | Name
2014 Top Stories in HIV Medicine by Paul Sax Posted in: Blog Posts in HIV & AIDS Boy do we love end-of-year “Best of …” and “Top Stories of …” lists! Love them! They never gets old! Until January, that is. My own particular favorites are the Best Movies ... Read on »
Holiday Season 2014 ID/HIV Link-O-Rama by Paul Sax Posted in: Blog Posts in HIV & AIDS A little spin around the internet brings us these ID/HIV tidbits, all of them designed to go well with holiday music, egg nog, and potato pancakes, plus a can’t-miss video c ... Read on »
CROI 2016 Dates Announced — You Read That Right — and What Will We Be Talking... by Paul Sax Posted in: Blog Posts in HIV & AIDS As any HIV/ID specialist knows, the Conference on Retroviruses and Opportunistic Infections, or CROI, is one of our very best (I think it’s the best) HIV scientific conferen ... Read on »
Five ID/HIV Things to be Grateful for this Holiday Season, 2014 Edition by Paul Sax Posted in: Blog Posts in HIV & AIDS Amidst outbreak hysterias, anti-vaccine imbecility, electronic medical record whining, and slug-related eosinophilia, I bring you this year’s version of the good news — the ... Read on »
Electronic Medical Records and the Demise of the Useful Medical Note by Paul Sax Posted in: Blog Posts in HIV & AIDS Electronic medical records (EMRs) are on my mind, as last week at Medical Grand Rounds Robert (Bob) Wachter, chief of the medical service at UCSF, gave a brilliant talk on t ... Read on »
Common Curbsides: The Tuberculin Skin Test and IGRA That Don’t Agree by Paul Sax Posted in: Blog Posts in HIV & AIDS Here’s one I’ve received twice in the past week, plus my answer. As always, names/some details changed to protect patient confidentiality, plus my annotations in brackets/it ... Read on »
Why the IPERGAY (Yes, That’s Its Name) Study Could Substantially Increase Use of PrEP by Paul Sax Posted in: Blog Posts in HIV & AIDS Yesterday, the French IPERGAY study of intermittent pre-exposure prophylaxis (PrEP) was stopped early by the Data Safety Monitoring Board, and for the best reason – the evid ... Read on »
IDSA Opposes Mandatory Quarantine of Healthcare Workers, and Andy Borowitz Is A Very... by Paul Sax Posted in: Blog Posts in HIV & AIDS From the Infectious Diseases Society of America (IDSA): Strategies to limit the potential for Ebola virus disease transmission from returning healthcare and humanitarian aid ... Read on »
What Makes An Ideal Applicant for a Fellowship in Infectious Diseases? by Paul Sax Posted in: Blog Posts in HIV & AIDS We’re at the tail end of the ID fellowship interview process, and am pleased to report we’ve seen some outstanding applicants. They know that our field is the most interesti ... Read on »
Almost Filovirus-Free (That is, Ebola-Free) ID Link-o-Rama by Paul Sax Posted in: Blog Posts in HIV & AIDS If you’re an ID doctor right now, the filovirus of the moment Ebola is consuming a big chunk of all of your non-clinical time — and this is particularly true for those heavi ... Read on »
Second U.S. Healthcare Worker with Ebola Further Underscores Urgent Need for Enhanced Preparedness... by Paul Sax Posted in: Blog Posts in HIV & AIDS If you’re like most of us, when you heard that a healthcare worker in Dallas had been diagnosed with Ebola virus disease, you assumed that the exposure occurred during his f ... Read on »
Approval of Sofosbuvir/Ledipasvir Was Expected, but Still Is a Huge Advance by Paul Sax Posted in: Blog Posts in HIV & AIDS As expected, the FDA just approved the first single-pill treatment for hepatitis C genotype 1, a tablet containing 400 mg of sofosbuvir (SOF) and 90 mg of ledipasvir (LDV). ... Read on »
Back to School: Questions from “ID in Primary Care” Course by Paul Sax Posted in: Blog Posts in HIV & AIDS Just wrapped our our annual postgraduate course, “Infectious Diseases in Primary Care,” where each year we get together with primary care providers (doctors, nurses, PAs) ... Read on »
New FDA HIV Drug Approvals Unlikely to Have Much Impact, Unless … by Paul Sax Posted in: Blog Posts in HIV & AIDS If you’re an ID doc based in the USA, you probably received notice last week that two new HIV drugs were approved — cobicistat and elvitegravir . And if you’re wonderi ... Read on »
Quick Question: How Do I Fill Out This Tricky Patient Job or School Form? by Paul Sax Posted in: Blog Posts in HIV & AIDS From a long-term and highly respected colleague comes this challenging query: Hi Paul, One of my HIV pts, doing wonderfully well, is planning to enroll in a nursin ... Read on »
In These Challenging Times for ID Doctors, A Little Comic Relief by Paul Sax Posted in: Blog Posts in HIV & AIDS I was passing a colleague in the hall the other day — he’s a general internist by training, now an important hospital administrator — and he briefly stopped me to get my t ... Read on »
It’s OK to Limit Who Prescribes HCV Therapy, but Insurers Shouldn’t Be Deciding by Paul Sax Posted in: Blog Posts in HIV & AIDS Some insurers would like to limit the prescribing of HCV treatment to gastroenterologists, hepatologists, or infectious diseases specialists. Not surprisingly, this doesn’ ... Read on »
How to Choose a Case for ID Case Conference by Paul Sax Posted in: Blog Posts in HIV & AIDS As August becomes September, ID fellows across the land are becoming increasingly skilled, heading rapidly upwards on that steep learning curve that is the first year of ... Read on »
Combination ABC/3TC/DTG Approved — Fourth One Pill a Day HIV Treatment by Paul Sax Posted in: Blog Posts in HIV & AIDS As expected, there’s a new single pill regimen for HIV, this one containing abacavir (ABC)/lamivudine (3TC)/dolutegravir (DTG), and it’s called Triumeq. (Where oh wh ... Read on »
Dietary Advice From Your Friendly ID Doc: Don’t Eat Garden Slugs by Paul Sax Posted in: Blog Posts in HIV & AIDS From the pages of Open Forum Infectious Diseases, comes this cautionary case report: Toxocariasis After Slug Ingestion Characterized by Severe Neurologic, Ocular, and P ... Read on »